Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) Nexus 2018
Drug Market to See More Competition, Launch of Biosimilars in 2019
October 23, 2018
Dr Aimee Tharaldson Outlines Current Key Market Trends in Specialty Pharmacy
October 23, 2018
Dr Jane F. Barlow: How Curative, High-Cost Therapies Bring Challenges to the Reimbursement Landscape
October 23, 2018
Law to Curb Opioid Abuse Will Have Many Managed Care Priorities, Experts Say
October 23, 2018
Analysis Finds HIV Therapy Biktarvy Associated With Cost Savings Compared With Most Regimens
October 24, 2018
Dr Christopher Diehl Explains the Pharmacist's Role in Value-Based Models
October 24, 2018
Dr Jennifer Graff on Using Real-World Evidence to Deliver High-Quality Care
October 24, 2018
CMS Audits Give View Into How Well Health Plans Deliver Medicare Programs
October 24, 2018
Massachusetts Medicaid Finds CAR T-Cell Payment Solution While Waiting on CMS
October 25, 2018
Dan Mendelson: Healthcare Policy Changes Avalere Health Is Paying Attention To
October 25, 2018
Currently Reading
Dr Kibum Kim on Precision Medicine in Managed Care
October 25, 2018
Dr Jane F. Barlow on How Curative, High-Cost Therapies Will Affect Patient OOP Costs
November 09, 2018
Dr Aimee Tharaldson: Recently Approved Specialty Drugs, Upcoming Approvals to Watch For
November 13, 2018
Dan Mendelson Discusses How Mergers and Acquisitions Are Affecting the Market
November 14, 2018
Dan Mendelson on the Trump Administration's Efforts to Lower Drug Prices
November 22, 2018
Dr Jane F. Barlow Discusses Potential New Reimbursement Models for New, High-Cost Therapies
November 27, 2018
Dan Mendelson's Expectations for Cross-Sector Mergers Like CVS, Aetna
November 28, 2018
Specialty Drug Approvals Dr Aimee Tharaldson is Looking Out for in 2019
November 29, 2018
Dan Mendelson on the Shift to Value-Based Care and Prescribing Patterns
December 22, 2018

Dr Kibum Kim on Precision Medicine in Managed Care

There has been dramatic growth in the number of labels relevant to precision medicine, but there remains a gap in the number available and what health plans actually cover, explained Kibum Kim, PhD, MSc, research assistant professor, University of Utah.


There has been dramatic growth in the number of labels relevant to precision medicine, but there remains a gap in the number available and what health plans actually cover, explained Kibum Kim, PhD, MSc, research assistant professor, University of Utah.

Transcript

Where are we currently with precision medicine in managed care?


My colleagues and I had a chance to look for recent studies into the recent shift and coverage for the use of precision medicine. Unfortunately, our effort resulted in a couple of studies dated back to 2012, meaning that it is a bit hard to see the movement over the last 5 years from publicly available data. In this report, there was a couple of key messages to us. The first thing we have to know about this precision medicine and companion diagnostics is how dynamic this area is.

In 2009, we had only about 50 medication labels relevant to precision medicine or pharmacogenomics. As of September 2018, the number of labeled precision medicine was approximately 300, meaning that we have seen a dramatic growth of this individualized or subpopulation specific intervention over the last 10 years.

The dynamic of precision medicine looks very hard to be captured by individual managed care plans or payers. This is to say why a systematic effort to summarize the recent trends in precision medicine in the setting of managed care is hard to be done and not published over the last 5 years. The most recently available data say that even the most evidence-proven technology was actually covered by around or less than 50% of the healthcare plans. Taking the dynamic of precision medicine in to consideration, it is inferred that the gap between the number of labeled precision medicine technology and the number of the coverage decision has continued or has become larger, which is corresponding to what has discussed by multiple representatives of managed care.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!